Table 1 Association between the clinicopathological data of CCA patients and HIPK3 expression levels.
Categories | Number of patients | HIPK3 expression H-score | p value | |
|---|---|---|---|---|
Low expression≦137 | High expression > 137 | |||
Gender | ||||
Female | 29 | 12 (13.6%) | 17 (19.3%) | 0.257 |
Male | 59 | 32 (36.4%) | 27 (30.7%) | |
Age(years) | ||||
≦56 | 45 | 23 (26.1%) | 22 (25.0%) | 0.831 |
 > 56 | 43 | 21 (23.9%) | 22 (25.0%) | |
Lymph node metastasis | ||||
No | 48 | 25 (28.4%) | 23 (26.1%) | 0.669 |
Yes | 40 | 19 (21.6%) | 21 (23.9%) | |
Tumor stage | ||||
I-III | 44 | 23 (26.1%) | 21 (23.9%) | 0.670 |
IVA-IVB | 44 | 21 (23.9%) | 23 (26.1%) | |
Histopathological grading | ||||
Non papillary | 44 | 21 (23.9%) | 23 (26.1%) | 0.670 |
Papillary | 44 | 23 (26.1%) | 21 (23.9%) | |
Survival days | ||||
≦380 | 44 | 27 (30.7%) | 17 (19.3%) | 0.033* |
  > 380 | 44 | 17 (19.3%) | 27 (30.7%) | |
